Trial Profile
A Randomised, Parallel Arm, Placebo-Controlled, Double-Blind, Study of the Safety and Efficacy of PRX167700 Added to Existing Non-steroidal Anti-inflammatory Therapy in Adults with Moderate-to-Severe Knee Pain Due to Osteoarthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2019
Price :
$35
*
At a glance
- Drugs PRX 167700 (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors BenevolentAI; Proximagen
- 06 Feb 2019 Status changed from recruiting to completed.
- 22 Nov 2018 This trial has been completed in Czech Republic.
- 15 Nov 2018 This trial has been completed in Hungary (End Date;2018-10-18)